Early research (Phase 1)WithdrawnNCT04941378
What this trial is testing
OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer
Who this might be right for
Ovarian Cancer
Abramson Cancer Center at Penn Medicine